Company profile

Pharnasanta Group is a global pharmaceutical holding company acting worldwide. The Group’s companies are focused on the production of generic drugs, pharmaceutical research and production, sales, and logistics.

European GMP certification, our own production team, and a wide range of worldwide logistics solutions have provided success in Europe as well as the CIS region while fueling expansion into the American market and opening up new opportunities around the globe.

The Group is able to provide clients with state-of-the-art solutions due to the following infrastructures:

  • Top-of-the-line global practices for developing biotech medicines
  • An internationally renowned R&D center
  • A cutting-edge pharmaceutical manufacturing complex
  • A portfolio of prominent international brands and products
  • Teams of highly qualified medical professionals
  • Global distribution channels paired with an experienced sales force

To provide the highest quality products and solutions we have set these three values as our core foundation:

  • Flexibility- In the medical field, staying flexible and innovative is the only way to keep up with the latest developments.
  • Efficiency- Lifesaving medicines and products are only beneficial if they are attainable. We know that being efficient is the only way to ensure that those in need can reach the help they deserve.
  • Competency- There is no industry that demands expert knowledge more than pharmaceuticals. We pride ourselves on a team of industry experts that thrives on the edge of new science.

As a global company, we focus innovation, quality, and precision. We understand that to provide the best possible service to our clients these traits have to be at the core of everything we do.

Linas Valentukevicius


The main shareholder of Pharnasanta Group is ZIA VALDA (and associated persons), with 57.5% of the shares. ZIA Valda has had great success from investment projects in fields such as aviation, real estate, and IT. For more than 20 years, ZIA Valda has operated across the markets of:

  • Central Europe
  • Eastern Europe
  • The CIS
  • Southeast Asia

Today, the ZIA Valda asset net value is worth more than EUR 250 million. Additionally, ZIA Valda has successfully executed or provided consultations for high figure projects such as:

  • Carrying out IPOs for 3 companies on OMX and WSE − worth more than USD 85 million
  • Supporting various Chinese Banks in regard to financing aircraft sale-leaseback transactions – worth more than USD 2 billion
  • Leading a team of experts in a successful working session to establish a Joint Venture engaged in aircraft leasing that lead to a deal − worth USD 900 million
Our slogan

Researching and producing so life can be enjoyed